Growth Metrics

ADC Therapeutics (ADCT) Receivables - Other (2021)

ADC Therapeutics has reported Receivables - Other over the past 1 years, most recently at $789000.0 for Q4 2021.

  • Quarterly results put Receivables - Other at $789000.0 for Q4 2021, changed N/A from a year ago — trailing twelve months through Dec 2021 was $789000.0 (changed N/A YoY), and the annual figure for FY2022 was $805000.0, up 2.03%.
  • Receivables - Other reached $789000.0 in Q4 2021 per ADCT's latest filing.
  • Across five years, Receivables - Other topped out at $789000.0 in Q4 2021 and bottomed at $789000.0 in Q4 2021.